Avid Bioservices, a contract development and manufacturing organization (CDMO) providing process development and CGMP manufacturing services for biopharmaceutical products, has appointed Rich McAvoy as Chief Business Officer (CBO).

McAvoy is a respected, business-oriented leader with deep experience spanning strategic investment management, operational finance, accounting, legal, compliance, and risk management. In his new role, he will help guide Avid’s growth strategy with a focus on disciplined execution, scalable operations, and outstanding customer delivery.

“As Avid enters its next chapter of growth, we are focused on scaling the organization in a way that strengthens execution and elevates the client experience,” said Kenneth Bilenberg, CEO of Avid Bioservices, who joined the company in September. “Rich is a thoughtful, highly capable leader with a strong reputation for building disciplined organizations that support reliable delivery. His ability to connect strategy to execution—while maintaining rigor in prioritization, compliance, and risk management—makes him an exceptional fit for Avid. We are excited to welcome Rich to the team as we expand our partnerships and continue raising the bar on what it means to be the easiest CDMO to work with.”

“Avid has built a strong reputation for quality and delivery, and I’m excited to join the team at a time when the company has clear growth ambitions,” said McAvoy. “My focus will be on disciplined execution —ensuring we continue delivering consistently and on time, while supporting an exceptional experience for our customers.”